NM_134323.2:c.44G>A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_134323.2(TARBP2):c.44G>A(p.Gly15Glu) variant causes a missense change. The variant allele was found at a frequency of 0.0000854 in 1,568,766 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_134323.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152248Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000284 AC: 5AN: 175930Hom.: 0 AF XY: 0.0000107 AC XY: 1AN XY: 93834
GnomAD4 exome AF: 0.0000868 AC: 123AN: 1416518Hom.: 0 Cov.: 31 AF XY: 0.0000843 AC XY: 59AN XY: 700296
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152248Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74384
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.44G>A (p.G15E) alteration is located in exon 1 (coding exon 1) of the TARBP2 gene. This alteration results from a G to A substitution at nucleotide position 44, causing the glycine (G) at amino acid position 15 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at